Verkazia Relaunch Opportunity to engage with pediatric ophthalmology clinics and allergy specialists to support the US relaunch of VERKAZIA, emphasizing access to FDA-approved VKC treatment for children and potential partnerships for payer coverage and patient access programs.

Payer Coverage Address the disclosed revenue shortfall tied to new commercial coverage and high-deductible patients by offering value-based contracts, patient assistance programs, or streamlined reimbursement support to reduce net revenue leakage and expand market adoption.

Early Growth Signals Capitalize on accelerating underlying demand for core ophthalmic products despite short-term revenue factors by targeting ophthalmology practices, pediatric ophthalmology, and allergy clinics with education on product benefits and procurement efficiency.

Strategic Events Leverage management’s appearances at investor conferences and public announcements to coordinate targeted outreach to growth-oriented distributors, specialty pharmacies, and ophthalmic networks ahead of upcoming product launches or expansions.

Expansion Readiness Position against national expansion needs by offering scalable supply chain and logistics solutions, digital outreach, and contract manufacturing partnerships to support Harrow's growth trajectory and broaden geographic coverage.